News
Public · Published
CLVT: LS&H sale sharpens the focus as organic growth and margins build momentum
Clarivate reported third-quarter organic ACV growth, which means growth in annual contract value, of 1.8%. Recurring revenue gains and cost discipline helped expand margins, which means profit per sale rose. The company sold its LS&H business for $600M to refocus its portfolio, and FY26 guidance points to $320M-$340M free cash flow and $865M-$885M Adjusted EBITDA.
Published:
Updated:
What happened
Clarivate reported third-quarter organic ACV growth, which means growth in annual contract value, of 1.8%. Recurring revenue gains and cost discipline helped expand margins, which means profit per sale rose. The company sold its LS&H business for $600M to refocus its portfolio, and FY26 guidance points to $320M-$340M free cash flow and $865M-$885M Adjusted EBITDA.
Confirmed
Global impact / market context
The $600M LS&H sale removes a business line, so remaining revenue must carry growth. Recurring revenue and cost discipline can lift profit per sale, and the $320M-$340M free cash flow guidance shows cash available after spending, which matters for debt reduction, buybacks, or reinvestment.
Analyst inference
Clarivate is being judged on organic growth and profit per sale rather than deal-making. The 1.8% organic ACV growth is modest, so margin gains and the $600M sale proceeds carry the story. FY26 free cash flow and Adjusted EBITDA guidance, which means earnings before interest, taxes, depreciation, and amortization, set the bar investors will track.
Analyst inference
What to watch
- Watch whether organic ACV growth, which means annual contract value growth from existing operations, stays near 1.8% or accelerates, since that measure shows whether the core business is winning new and renewed customer contracts. Confirmed
- Watch how Clarivate uses the $600M LS&H sale proceeds, whether for debt reduction, buybacks, or reinvestment, because management has not specified a use in the supplied summary. Proposed
- Watch whether recurring revenue gains and cost discipline keep expanding margins, since that drives the $865M-$885M Adjusted EBITDA and $320M-$340M free cash flow guidance for FY26. Analyst inference
Evidence
- Original source link unavailable